PhenixFIN Corporation (PFX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PFX SEC filings page.
This page shows PhenixFIN Corporation (PFX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025’s larger balance sheet generated much less income and cash, while rising liabilities increased the cost of financing growth.
From FY2024 to FY2025, net income fell from$18.6M to$4.2M . Operating cash flow simultaneously swung from$16.1M to-$67.3M , indicating that reported earnings became a poor guide to cash produced by the business.
From FY2023 to FY2025, total assets grew
Interest expense rose
Financial Health Signals
PhenixFIN Corporation does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
PhenixFIN Corporation passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
Key Financial Metrics
Earnings & Revenue
PhenixFIN Corporation reported $4.2M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 272.9%.
PhenixFIN Corporation earned $2.19 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 284.2%.
Not reported for Q3 2026.
Not reported for Q3 2026.
Cash & Balance Sheet
PhenixFIN Corporation held $2.2M in cash against $146.8M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
PhenixFIN Corporation's quarterly ROE was 2.7% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
PhenixFIN Corporation spent $31K on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 99.0%.
Not reported for Q3 2026.
Not reported for Q3 2026.
PFX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $355K-10.8% | $362K+17.8% | $360K+62.5% | N/A | $398K+75.6% | $308K-1.0% | $222K-31.8% | N/A |
| Interest Expense | $2.3M-12.8% | $2.3M-10.5% | $2.4M-4.5% | N/A | $2.7M+54.5% | $2.6M+64.6% | $2.5M+65.1% | N/A |
| Net Income | $4.2Mn/m | $1.1Mn/m | -$4.8M-293.6% | N/A | -$1.5M-157.4% | -$896K-116.7% | $2.5M-45.6% | N/A |
| EPS (Basic) | $2.19n/m | $0.57n/m | -$2.38-295.1% | $2.03-32.8% | -$0.74-157.4% | -$0.44-116.8% | $1.22-44.3% | $3.02-14.4% |
| EPS (Diluted) | $2.19n/m | $0.57n/m | -$2.38-295.1% | $2.03-32.8% | -$0.74-157.4% | -$0.44-116.8% | $1.22-44.3% | $3.02-14.4% |
| Diluted Shares (Avg) | 2M-4.2% | 2M-2.3% | 2M-0.9% | N/A | 2M-0.1% | 2M-1.4% | 2M-2.6% | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax.
PFX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $309.9M+1.0% | $305.6M+1.6% | $307.4M-1.5% | $316.9M+4.7% | $306.8M+24.6% | $300.7M+21.4% | $311.9M+31.1% | $302.8M+26.3% |
| Cash & Equivalents | $2.2M-69.9% | $3.1M-64.4% | $3.4M-52.8% | $7.3M-89.2% | $7.3M-18.0% | $8.7M-54.5% | $7.2M-41.0% | $67.6M+1026.7% |
| Total Liabilities | $152.0M+1.3% | $151.8M+7.1% | $151.6M+1.6% | $156.1M+9.6% | $150.1M+63.0% | $141.7M+51.7% | $149.2M+71.2% | $142.4M+53.2% |
| Long-Term Debt | $146.8M+1.2% | $146.8M+6.7% | $146.7M+3.4% | $148.1M+9.1% | $145.1M+70.1% | $137.5M+62.9% | $141.8M+68.1% | $135.8M+61.2% |
| Total Equity | $157.9M+0.7% | $153.8M-3.3% | $155.8M-4.3% | $160.8M+0.3% | $156.7M+1.6% | $159.0M+3.1% | $162.8M+8.0% | $160.3M+9.3% |
| Retained Earnings | -$543.4Mn/m | -$547.5Mn/m | -$548.6Mn/m | -$543.9Mn/m | -$547.4Mn/m | -$545.9Mn/m | -$542.1Mn/m | -$544.6Mn/m |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
PFX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$694Kn/m | $2.7M-69.2% | -$2.0Mn/m | -$3.0M-134.1% | -$6.9Mn/m | $8.8M-1.9% | -$66.3M-1081.1% | $8.7Mn/m |
| Financing Cash Flow | -$203K-103.7% | -$3.0Mn/m | -$1.8M-131.3% | $3.0M-94.0% | $5.5Mn/m | -$7.3Mn/m | $5.9Mn/m | $50.0Mn/m |
| Dividends Paid | N/A | N/A | N/A | $0n/m | $0 | N/A | N/A | $0 |
| Share Buybacks | $31K | $3.1M | $183K | $5Kn/m | N/A | N/A | N/A | $0-100.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow.
PFX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | 2.7%+3.6pp | 0.7%+1.3pp | -3.1%-4.6pp | N/A | -1.0%-2.6pp | -0.6%-4.0pp | 1.5%-1.5pp | N/A |
| Return on Assets | 1.4%+1.8pp | 0.4%+0.7pp | -1.6%-2.3pp | N/A | -0.5%-1.6pp | -0.3%-2.5pp | 0.8%-1.1pp | N/A |
| Debt-to-Equity | 0.930.0x | 0.95+0.1x | 0.94+0.1x | 0.92+0.1x | 0.93+0.4x | 0.86+0.3x | 0.87+0.3x | 0.85+0.3x |
| Liabilities-to-Equity | 0.960.0x | 0.99+0.1x | 0.97+0.1x | 0.97+0.1x | 0.96+0.4x | 0.89+0.3x | 0.92+0.3x | 0.89+0.3x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| PhenixFIN Corporation PFX | FY2025 | N/A | $4.2M | N/A | $82.5M | — |
| OFS Capital Corporation OFS | FY2025 | N/A | -$33.1M | N/A | $52.5M | — |
Where PhenixFIN Corporation Ranks
Frequently Asked Questions
Is PhenixFIN Corporation profitable?
Yes, PhenixFIN Corporation (PFX) reported a net income of $4.2M in fiscal year 2025.
How much debt does PhenixFIN Corporation have?
As of fiscal year 2025, PhenixFIN Corporation (PFX) had $7.3M in cash and equivalents against $148.1M in long-term debt.
What is PhenixFIN Corporation's return on equity (ROE)?
PhenixFIN Corporation (PFX) has a return on equity of 2.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is PhenixFIN Corporation's operating cash flow?
PhenixFIN Corporation (PFX) recorded an outflow of $67.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are PhenixFIN Corporation's total assets?
PhenixFIN Corporation (PFX) had $316.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What is PhenixFIN Corporation's debt-to-equity ratio?
PhenixFIN Corporation (PFX) had a debt-to-equity ratio of 0.92 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is PhenixFIN Corporation's liabilities-to-equity ratio?
PhenixFIN Corporation (PFX) had a liabilities-to-equity ratio of 0.97 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is PhenixFIN Corporation's return on assets (ROA)?
PhenixFIN Corporation (PFX) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is PhenixFIN Corporation's P/E ratio?
PhenixFIN Corporation (PFX) trades at 19.8x earnings, its market capitalization divided by $4.2M net income, FY2025. The market capitalization is $82.5M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is PhenixFIN Corporation's price-to-sales ratio?
PhenixFIN Corporation (PFX) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $82.5M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is PhenixFIN Corporation's Piotroski F-Score?
PhenixFIN Corporation (PFX) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.